Kanoria Chemicals & Industries Ltd: Valuation Shifts Signal Changing Price Attractiveness

Valuation Metrics: From Attractive to Fair

Kanoria Chemicals currently trades at a P/E ratio of 11.25 and a P/BV of 1.20, marking a shift from previously attractive valuation levels to a fair valuation grade as of 4 May 2026. This change reflects a recalibration of investor expectations and market pricing, influenced by the company’s recent financial performance and sector dynamics. The enterprise value to EBITDA (EV/EBITDA) ratio stands at 9.80, while the EV to EBIT is 15.41, indicating moderate valuation multiples relative to earnings and operating profits.

Compared to its peers in the commodity chemicals industry, Kanoria Chemicals’ valuation remains reasonable. For instance, J.G. Chemicals trades at a significantly higher P/E of 31.15 and EV/EBITDA of 22.86, while Indo Borax & Chemicals and Titan Biotech are classified as very expensive with P/E ratios exceeding 30 and EV/EBITDA multiples above 26 and 37 respectively. This positions Kanoria Chemicals as a more moderately priced option within its sector.

Peer Comparison Highlights

Peer companies such as I G Petrochems and Nitta Gelatin also command higher valuations, with P/E ratios of 18.9 and 13.83 respectively, and EV/EBITDA multiples below Kanoria Chemicals in some cases but still reflecting a more expensive market stance. On the other hand, TGV Sraac is noted as very attractive with a P/E of 8.19 and EV/EBITDA of 3.75, underscoring the diversity in valuation within the sector.

Kanoria Chemicals’ PEG ratio is effectively zero, indicating that the stock’s price is not currently factoring in significant earnings growth expectations, which may be a point of consideration for investors seeking growth-oriented opportunities.

Financial Performance and Returns Contextualised

Kanoria Chemicals’ return metrics have been impressive, particularly when benchmarked against the broader Sensex index. Year-to-date (YTD), the stock has surged by 103.16%, vastly outperforming the Sensex’s negative 9.21% return over the same period. Over the past year, the stock has delivered an 82.47% gain compared to a 4.84% decline in the Sensex, highlighting strong investor confidence and operational resilience.

Longer-term returns also demonstrate solid performance, with a three-year return of 35.16% versus Sensex’s 18.57%, and a ten-year return of 120.69% compared to the Sensex’s 175.73%. Although the ten-year outperformance is less pronounced, the stock’s recent momentum and valuation shift suggest a positive trajectory.

Profitability and Efficiency Metrics

Kanoria Chemicals’ return on capital employed (ROCE) stands at 4.26%, while return on equity (ROE) is 6.97%. These figures indicate moderate profitability levels, which may partly explain the fair valuation grade. The company’s enterprise value to capital employed ratio is 1.13, and EV to sales is 0.78, reflecting a relatively conservative valuation relative to its asset base and revenue generation.

Dividend yield data is not available, which may be a consideration for income-focused investors. The company’s micro-cap status also suggests a degree of volatility and liquidity considerations that investors should factor into their decision-making process.

Market Price and Trading Range

As of 25 August 2026, Kanoria Chemicals closed at ₹155.70, up 1.67% from the previous close of ₹153.15. The stock traded within a range of ₹153.45 to ₹157.75 during the day, maintaining proximity to its 52-week high of ₹167.90. The 52-week low stands at ₹55.72, underscoring significant appreciation over the past year.

Implications for Investors

The transition from an attractive to a fair valuation grade suggests that Kanoria Chemicals’ stock price has adjusted to reflect its current earnings and growth outlook more accurately. While the P/E ratio of 11.25 remains below many peers, the company’s moderate profitability and micro-cap status warrant a cautious approach.

Investors should weigh the company’s strong recent returns and reasonable valuation against its relatively modest ROCE and ROE figures. The absence of a dividend yield and the zero PEG ratio indicate limited growth expectations priced in, which could present upside potential if earnings accelerate.

Given the stock’s significant outperformance relative to the Sensex over the past year and year-to-date, Kanoria Chemicals may appeal to investors seeking exposure to the commodity chemicals sector with a value tilt. However, the fair valuation grade and micro-cap classification suggest that risk management and portfolio diversification remain important considerations.

Conclusion

Kanoria Chemicals & Industries Ltd’s valuation shift from attractive to fair reflects a maturing market perception amid strong stock price appreciation and solid returns. Its valuation multiples remain reasonable compared to expensive peers, but moderate profitability metrics and micro-cap risks temper enthusiasm. Investors should monitor earnings trends and sector developments closely to assess whether the stock’s fair valuation can evolve into renewed attractiveness.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →